Advertisement

CEN Case Reports

, Volume 7, Issue 2, pp 211–216 | Cite as

A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren’s syndrome

  • Masaki Yamanaka
  • Yoshihide Fujigaki
  • Hajime Kono
  • Michito Nagura
  • Shigeyuki Arai
  • Yoshifuru Tamura
  • Tatsuru Ota
  • Shigeru Shibata
  • Fukuo Kondo
  • Yutaka Yamaguchi
  • Shunya Uchida
Case Report

Abstract

Autoimmune diseases are sometimes associated with immune-mediated renal diseases and cryoglobulinemia is one of the causes. Cryoglobulinemia and cryoglobulinemic glomerulonephritis associated with primary Sjögren’s syndrome are most frequent condition among non-hepatitis C virus-related condition. Its typical renal manifestation shows high amount of proteinuria with microscopic hematuria and renal insufficiency. We describe a case of 72-year-old woman with Hashimoto disease, autoimmune hepatitis, Sjögren’s syndrome, and immune-related pancytopenia complicated by cryoglobulinemic glomerulonephritis. Before kidney biopsy, tubulointerstitial nephritis probably due to Sjögren’s syndrome was suspected because of persistent hematuria without significant proteinuria and developing mild renal dysfunction over 6 months. The developing renal dysfunction associated with isolated hematuria is uncommon in glomerular diseases. Kidney biopsy, however, revealed established membranoproliferative glomerulonephritis with subendothelial deposits consisting of tubular structures with IgM, IgG, and C3 staining. Corticosteroids plus mycophenolate mofetil therapy successfully normalized renal function. Physician should not overlook cryoglobulinemic glomerulonephritis, which is potentially poor prognosis, even if urinalysis shows only persistent isolated hematuria in patients with autoimmune diseases.

Keywords

Autoimmune disease Cryoglobulinemic glomerulonephritis Isolated hematuria Membranoproliferative glomerulonephritis Mycophenolate mofetil, Sjögren’s syndrome 

Notes

Acknowledgements

We would like to thank Ms. Hiromi Yamaguchi for her technical assistance.

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Written informed consent was obtained from the patient.

References

  1. 1.
    Matignon M, Cacoub P, Colombat M, Saadoun D, Brocheriou I, Mougenot B, Roudot-Thoraval F, Vanhille P, Moranne O, Hachulla E, Hatron PY, Fermand JP, Fakhouri F, Ronco P, Plaisier E, Grimbert P. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore). 2009;88:341–8.CrossRefGoogle Scholar
  2. 2.
    Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, Bridoux F, Vanhille P, Makdassi R, Augusto JF, Rouvier P, Karras A, Jouanneau C, Verpont MC, Callard P, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Saadoun D, Ronco P, Brochériou I, Cacoub P, Plaisier E. CryoVas study group. Spectrum and prognosis of noninfectious renal mixed cryoglobulinemic GN. J Am Soc Nephrol. 2016;27:1213–24.CrossRefGoogle Scholar
  3. 3.
    Anand A, Krishna GG, Sibley RK, Kambham N. Sjögren syndrome and cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2015;66:532–5.CrossRefGoogle Scholar
  4. 4.
    Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, Candela M, Ferri C, Gabrielli A, Mazzaro C, Migliaresi S, Mussini C, Ossi E, Quintiliani L, Tirri G, Vacca A. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995;88:115–26.PubMedGoogle Scholar
  5. 5.
    Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC. Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.CrossRefGoogle Scholar
  6. 6.
    Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine (Baltimore). 2000;79:241–9.CrossRefGoogle Scholar
  7. 7.
    Morimoto C, Fujigaki Y, Tamura Y, Ota T, Shibata S, Asako K, Kikuchi H, Kono H, Kondo F, Yamaguchi Y, Uchida S. Emergence of smoldering ANCA-associated glomerulonephritis during the clinical course of mixed connective tissue disease and Sjögren’s syndrome. Intern Med. 2017.  https://doi.org/10.2169/internalmedicine.9844-17.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wheeler DS, Giugliano RP, Rangaswami J. Anticoagulation-related nephropathy. J Thromb Haemost. 2016;14:461–7.CrossRefGoogle Scholar
  9. 9.
    Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren’s syndrome. Thyroid. 2009;19:39–45.CrossRefGoogle Scholar
  10. 10.
    Ramos-Casals M, Stone JH, Cid MC, Bosh X. The cryoglobulinaemias. Lancet. 2012;379:348–60.CrossRefGoogle Scholar
  11. 11.
    Zhao Y, Li Y, Wang L, Li XF, Huang CB, Wang GC, Zhang XW, Zhang ZL, Zhang X, Xiao WG, Dai L, Wang YF, Hu SX, Li HB, Gong L, Liu B, Sun LY, Zhang MJ, Zhang X, Li YZ, Du DS, Zhang SH, Sun YY, Zhang FC. Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients. Medicine (Baltimore). 2015;94:e667.CrossRefGoogle Scholar
  12. 12.
    Retamozo S, Gheitasi H, Quartuccio L, Kostov B, Corazza L, Bové A, Sisó-Almirall A, Gandía M, Ramos-Casals M, De Vita S, Brito-Zerón P. Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients. Rheumatology. 2016;55:1443–51.CrossRefGoogle Scholar
  13. 13.
    Willeke P, Schlüter B, Becker H, Schotte H, Domschke W, Gaubitz M. Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial. Arthritis Res Ther. 2007;9:R115.CrossRefGoogle Scholar
  14. 14.
    Koratala A, Reeves WH, Segal MS. Tubulointerstitial nephritis in sjögren syndrome treated with mycophenolate mofetil. J Clin Rheumatol. 2017;23:402–3.CrossRefGoogle Scholar
  15. 15.
    Pereira PR, Viala K, Maisonobe T, Haroche J, Mathian A, Hié M, Amoura Z, Cohen Aubart F. Sjögren sensory neuronopathy (Sjögren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine (Baltimore). 2016;95:e3632.CrossRefGoogle Scholar
  16. 16.
    Colucci G, Manno C, Grandaliano G, Schena FP. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy. Clin Nephrol. 2011;75:374–9.CrossRefGoogle Scholar
  17. 17.
    Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980;69:287–308.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • Masaki Yamanaka
    • 1
  • Yoshihide Fujigaki
    • 1
  • Hajime Kono
    • 1
  • Michito Nagura
    • 1
  • Shigeyuki Arai
    • 1
  • Yoshifuru Tamura
    • 1
  • Tatsuru Ota
    • 1
  • Shigeru Shibata
    • 1
  • Fukuo Kondo
    • 2
  • Yutaka Yamaguchi
    • 2
  • Shunya Uchida
    • 1
  1. 1.Department of Internal MedicineTeikyo University School of MedicineTokyoJapan
  2. 2.Department of PathologyTeikyo University HospitalTokyoJapan

Personalised recommendations